Hospital
Marshall County Hospital District
Marshall County Hospital District was paid $9.23M by Medicaid between Jan 2018 and Nov 2024, across 106 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 21% of everything it billed.
33Billing provider infoMARSHALL COUNTY HOSPITAL DISTRICT
BENTON, KY 42025
BENTON, KY 42025
33aNPI1568528594assigned 12/27/2006
33bProvider typeCritical Access Hospital
28Total paid$9.23M
24GClaims153,471
24DCodes billed106
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Kentucky
Rank by total paid#12 of 16
Median peer was paid$11.73M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,117 | $1.09M | |
| 2019 | 23,036 | $1.22M | |
| 2020 | 18,530 | $994K | |
| 2021 | 25,052 | $1.41M | |
| 2022 | 25,621 | $1.70M | |
| 2023 | 23,245 | $1.61M | |
| 2024incomplete | 16,870 | $1.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 21% | 2,418 | 2,121 | $1.97M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 6,789 | 5,885 | $1.52M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15% | 9,122 | 8,154 | $1.40M |
| 70450 | Computed tomography, head or brain; without contrast material | 9.5% | 2,039 | 1,700 | $877K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.0% | 2,440 | 1,982 | $646K |
| 80053 | Comprehensive metabolic panel | 2.6% | 13,265 | 10,172 | $242K |
| 71045 | Radiologic examination, chest; single view | 2.3% | 2,742 | 2,363 | $208K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.1% | 3,506 | 741 | $195K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.1% | 1,519 | 1,305 | $189K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 3,295 | 2,818 | $178K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 24,573 | 12,946 | $167K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 11,486 | 9,333 | $146K |
94 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 1,354 | $109K |
| 99285 | Emergency room visit (most serious) | 1.1% | 311 | $101K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 977 | $62K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,121 | $59K |
| 87486 | <1% | 1,820 | $59K | |
| 87581 | <1% | 1,788 | $57K | |
| 80061 | Lipid panel | <1% | 2,101 | $56K |
| 84484 | <1% | 2,930 | $40K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,647 | $40K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 561 | $39K |
| 83735 | <1% | 3,270 | $37K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 446 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,256 | $34K |
| J3490 | Unclassified drugs | <1% | 2,556 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,532 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,092 | $31K |
| 83690 | <1% | 2,595 | $28K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 523 | $28K |
| 81001 | <1% | 2,711 | $27K | |
| 82550 | <1% | 2,918 | $27K | |
| 82553 | <1% | 2,350 | $26K | |
| 73630 | <1% | 165 | $26K | |
| 82150 | <1% | 2,550 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 608 | $23K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 605 | $22K |
| 81025 | <1% | 1,545 | $22K | |
| 80305 | <1% | 914 | $21K | |
| 83615 | <1% | 2,246 | $20K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 38 | $19K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 416 | $19K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,467 | $18K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 726 | $18K |
| 99235 | <1% | 43 | $17K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 279 | $16K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 299 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 149 | $16K |
| 73130 | <1% | 100 | $14K | |
| 73610 | <1% | 59 | $12K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 245 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,754 | $11K |
| 81003 | <1% | 2,021 | $10K | |
| 85379 | <1% | 293 | $9K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 822 | $8K |
| 85027 | <1% | 761 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 235 | $7K |
| 72131 | <1% | 14 | $7K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 971 | $7K |
| 99234 | <1% | 15 | $7K | |
| 87081 | <1% | 789 | $7K | |
| 87077 | <1% | 534 | $6K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 224 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 582 | $6K |
| 71250 | <1% | 12 | $6K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 96 | $6K |
| J2704 | Injection, propofol, 10 mg | <1% | 689 | $6K |
| 90715 | <1% | 56 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 380 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 60 | $5K |
| 82607 | <1% | 303 | $4K | |
| 86140 | <1% | 547 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 712 | $4K |
| 85007 | <1% | 762 | $4K | |
| 85610 | <1% | 416 | $4K | |
| 87040 | <1% | 65 | $3K | |
| 85651 | <1% | 236 | $3K | |
| 87184 | <1% | 241 | $3K | |
| 73030 | <1% | 12 | $3K | |
| 73110 | <1% | 14 | $2K | |
| 83880 | <1% | 98 | $2K | |
| 87430 | <1% | 141 | $2K | |
| 87400 | <1% | 100 | $2K | |
| 97162 | <1% | 33 | $2K | |
| 12001 | <1% | 13 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 296 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 352 | $2K |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 120 | $1K |
| 80320 | <1% | 95 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 30 | $1K |
| 86710 | <1% | 56 | $973.48 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 215 | $957.70 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 102 | $941.29 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 149 | $711.56 |
| 85730 | <1% | 71 | $691.47 | |
| 86762 | <1% | 26 | $499.06 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 46 | $476.03 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 245 | $471.38 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $434.83 |
| 97750 | <1% | 12 | $411.14 | |
| 36600 | <1% | 31 | $341.48 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 46 | $292.50 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 18 | $177.53 |
| 84703 | <1% | 12 | $173.87 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 15 | $114.45 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 14 | $43.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFUQUA, DAVID (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Marshall County Hospital District | Benton, KY | $115K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.